|
1
|
Siegel RL, Miller KD, Fuchs HE and Jemal
A: Cancer statistics, 2022. CA Cancer J Clin. 72:7–33. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hwang RF, Moore T, Arumugam T,
Ramachandran V, Amos KD, Rivera A, Ji B, Evans DB and Logsdon CD:
Cancer-associated stromal fibroblasts promote pancreatic tumor
progression. Cancer Res. 68:918–926. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Orozco CA, Martinez-Bosch N, Guerrero PE,
Vinaixa J, Dalotto-Moreno T, Iglesias M, Moreno M, Djurec M,
Poirier F, Gabius HJ, et al: Targeting galectin-1 inhibits
pancreatic cancer progression by modulating tumor-stroma crosstalk.
Proc Natl Acad Sci USA. 115:E3769–E3778. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Guan J, Zhang H, Wen Z, Gu Y, Cheng Y, Sun
Y, Zhang T, Jia C, Lu Z and Chen J: Retinoic acid inhibits
pancreatic cancer cell migration and EMT through the downregulation
of IL-6 in cancer associated fibroblast cells. Cancer Lett.
345:132–139. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ireland L, Santos A, Ahmed MS, Rainer C,
Nielsen SR, Quaranta V, Weyer-Czernilofsky U, Engle DD,
Perez-Mancera PA, Coupland SE, et al: Chemoresistance in pancreatic
cancer is driven by stroma-derived insulin-like growth factors.
Cancer Res. 76:6851–6863. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wei L, Ye H, Li G, Lu Y, Zhou Q, Zheng S,
Lin Q, Liu Y, Li Z and Chen R: Cancer-associated fibroblasts
promote progression and gemcitabine resistance via the SDF-1/SATB-1
pathway in pancreatic cancer. Cell Death Dis. 9:10652018.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Su S, Chen J, Yao H, Liu J, Yu S, Lao L,
Wang M, Luo M, Xing Y, Chen F, et al: CD10 + GPR77 +
cancer-associated fibroblasts promote cancer formation and
chemoresistance by sustaining cancer stemness. Cell. 172:841–856.
e162018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pelon F, Bourachot B, Kieffer Y, Magagna
I, Mermet-Meillon F, Bonnet I, Costa A, Givel AM, Attieh Y,
Barbazan J, et al: Cancer-associated fibroblast heterogeneity in
axillary lymph nodes drives metastases in breast cancer through
complementary mechanisms. Nat Commun. 11:4042020. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Elyada E, Bolisetty M, Laise P, Flynn WF,
Courtois ET, Burkhart RA, Teinor JA, Belleau P, Biffi G, Lucito MS,
et al: Cross-species single-cell analysis of pancreatic ductal
adenocarcinoma reveals antigen-presenting cancer-associated
fibroblasts. Cancer Discov. 9:1102–1123. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Biffi G, Oni TE, Spielman B, Hao Y, Elyada
E, Park Y, Preall J and Tuveson DA: IL1-induced JAK/STAT signaling
is antagonized by TGFβ to shape CAF heterogeneity in pancreatic
ductal adenocarcinoma. Cancer Discov. 9:282–301. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Pilleron S, Sarfati D, Janssen-Heijnen M,
Vignat J, Ferlay J, Bray F and Soerjomataram I: Global cancer
incidence in older adults, 2012 and 2035: A population-based study.
Int J Cancer. 144:49–58. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Balducci L and Ershler WB: Cancer and
ageing: A nexus at several levels. Nat Rev Cancer. 5:655–662. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lee S and Schmitt CA: The dynamic nature
of senescence in cancer. Nat Cell Biol. 21:94–101. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Childs BG, Gluscevic M, Baker DJ, Laberge
RM, Marquess D, Dananberg J and van Deursen JM: Senescent cells: An
emerging target for diseases of ageing. Nat Rev Drug Discov.
16:718–735. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Micco RD, Krizhanovsky V, Baker D and di
Fagagna F: Cellular senescence in ageing: From mechanisms to
therapeutic opportunities. Nat Rev Mol Cell Biol. 22:75–95. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ovadya Y and Krizhanovsky V: Strategies
targeting cellular senescence. J Clin Invest. 128:1247–1254. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sun Y, Coppé JP and Lam EWF: Cellular
senescence: The sought or the unwanted? Trends Mol Med. 24:871–885.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kuilman T, Michaloglou C, Vredeveld LCW,
Douma S, van Doorn R, Desmet CJ, Aarden LA, Mooi WJ and Peeper DS:
Oncogene-induced senescence relayed by an interleukin-dependent
inflammatory network. Cell. 133:1019–1031. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Acosta JC, O'Loghlen A, Banito A, Guijarro
MV, Augert A, Raguz S, Fumagalli M, Costa MD, Brown C, Popov N, et
al: Chemokine signaling via the CXCR2 receptor reinforces
senescence. Cell. 133:1006–1018. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Coppé JP, Patil CK, Rodier F, Sun Y, Muñoz
DP, Goldstein J, Nelson PS, Desprez PY and Campisi J:
Senescence-associated secretory phenotypes reveal
cell-nonautonomous functions of oncogenic RAS and the p53 tumor
suppressor. PLoS Biol. 6:e3012008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yoshimoto S, Loo TM, Atarashi K, Kanda H,
Sato S, Oyadomari S, Iwakura Y, Oshima K, Morita H, Hattori M, et
al: Obesity-induced gut microbial metabolite promotes liver cancer
through senescence secretome. Nature. 499:97–101. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Guo Y, Ayers JL, Carter KT, Wang T, Maden
SK, Edmond D, Newcomb P, Li C, Ulrich C, Yu M, et al:
Senescence-associated tissue microenvironment promotes colon cancer
formation through the secretory factor GDF15. Aging Cell.
18:e130132019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Toso A, Revandkar A, Mitri DD, Guccini I,
Proietti M, Sarti M, Pinton S, Zhang J, Kalathur M, Civenni G, et
al: Enhancing chemotherapy efficacy in Pten-deficient prostate
tumors by activating the senescence-associated antitumor immunity.
Cell Rep. 9:75–89. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bachem MG, Schünemann M, Ramadani M, Siech
M, Beger H, Buck A, Zhou S, Schmid-Kotsas A and Adler G: Pancreatic
carcinoma cells induce fibrosis by stimulating proliferation and
matrix synthesis of stellate cells. Gastroenterology. 128:907–921.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mukai Y, Yamada D, Eguchi H, Iwagami Y,
Asaoka T, Noda T, Kawamoto K, Gotoh K, Kobayashi S, Takeda Y, et
al: Vitamin D supplementation is a promising therapy for pancreatic
ductal adenocarcinoma in conjunction with current chemoradiation
therapy. Ann Surg Oncol. 25:1868–1879. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Crochemore C, Fernández-Molina C, Montagne
B, Salles A and Ricchetti M: CSB promoter downregulation via
histone H3 hypoacetylation is an early determinant of replicative
senescence. Nat Commun. 10:55762019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Vasef MA, Ross JS and Cohen MB: Telomerase
activity in human solid tumors. Diagnostic utility and clinical
applications. Am J Clin Pathol. 112:S68–S75. 1999.PubMed/NCBI
|
|
29
|
Uehara H, Nakaizumi A, Tatsuta M, Baba M,
Takenaka A, Uedo N, Sakai N, Yano H, Iishi H, Ohigashi H, et al:
Diagnosis of pancreatic cancer by detecting telomerase activity in
pancreatic juice: Comparison with K-ras mutations. Am J
Gastroenterol. 94:2513–2518. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sharpless NE and Sherr CJ: Forging a
signature of in vivo senescence. Nat Rev Cancer. 15:397–408. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hara E, Smith R, Parry D, Tahara H, Stone
S and Peters G: Regulation of p16CDKN2 expression and its
implications for cell immortalization and senescence. Mol Cell
Biol. 16:859–867. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Alcorta DA, Xiong Y, Phelps D, Hannon G,
Beach D and Barrett JC: Involvement of the cyclin-dependent kinase
inhibitor p16 (INK4a) in replicative senescence of normal human
fibroblasts. Proc Natl Acad Sci USA. 93:13742–13747. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kang C, Xu Q, Martin TD, Li MZ, Demaria M,
Aron L, Lu T, Yankner BA, Campisi J and Elledge SJ: The DNA damage
response induces inflammation and senescence by inhibiting
autophagy of GATA4. Science. 349:aaa56122015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Strzeszewska A, Alster O, Mosieniak G,
Ciolko A and Sikora E: Insight into the role of PIKK family members
and NF-кB in DNAdamage-induced senescence and senescence-associated
secretory phenotype of colon cancer cells. Cell Death Dis.
9:442018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yang M, Jiang Z, Yao G, Wang Z, Sun J, Qin
H and Zhao H: GALC Triggers tumorigenicity of colorectal cancer via
senescent fibroblasts. Front Oncol. 10:3802020. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yang G, Rosen DG, Zhang Z, Bast RC Jr,
Mills GB, Colacino JA, Mercado-Uribe I and Liu J: The chemokine
growth-regulated oncogene 1 (Gro-1) links RAS signaling to the
senescence of stromal fibroblasts and ovarian tumorigenesis. Proc
Natl Acad Sci USA. 103:16472–16477. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Taddei ML, Cavallini L, Comito G, Giannoni
E, Folini M, Marini A, Gandellini P, Morandi A, Pintus G,
Raspollini MR, et al: Senescent stroma promotes prostate cancer
progression: The role of miR-210. Mol Oncol. 8:1729–1746. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Toste PA, Nguyen AH, Kadera BE, Duong M,
Wu N, Gawlas I, Tran LM, Bikhchandani M, Li L, Patel SG, et al:
Chemotherapy-induced inflammatory gene signature and
pro-tumorigenic phenotype in pancreatic CAFs via stress-associated
MAPK. Mol Cancer Res. 14:437–447. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Coppé JP, Desprez PY, Krtolica A and
Campisi J: The senescence-associated secretory phenotype: The dark
side of tumor suppression. Annu Rev Pathol. 5:99–118. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Harley CB, Futcher AB and Greider CW:
Telomeres shorten during ageing of human fibroblasts. Nature.
345:458–460. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Hernandez-Segura A, Brandenburg S and
Demaria M: Induction and validation of cellular senescence in
primary human cells. J Vis Exp. 20:577822018.PubMed/NCBI
|
|
42
|
Dierick JF, Eliaers F, Remacle J, Raes M,
Fey SJ, Larsen PM and Toussaint O: Stress-induced premature
senescence and replicative senescence are different phenotypes,
proteomic evidence. Biochem Pharmacol. 64:1011–1017. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zhu J, Singh M, Selivanova G and Peuget S:
Pifithrin-α alters p53 post-translational modifications pattern and
differentially inhibits p53 target genes. Sci Rep. 10:10492020.
View Article : Google Scholar : PubMed/NCBI
|
